Regen BioPharma Inc Quarterly Common Stock, Shares, Outstanding from Q3 2013 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Regen BioPharma Inc quarterly Common Stock, Shares, Outstanding history and growth rate from Q3 2013 to Q2 2024.
  • Regen BioPharma Inc Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 4.37M shares, a 29.3% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 4.37M +992K +29.3% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 4.11M +733K +21.7% Mar 31, 2024 10-Q 2024-04-24
Q4 2023 3.75M -50.8B -100% Dec 31, 2023 10-Q 2024-01-19
Q3 2023 3.51M +152K +4.52% Sep 30, 2023 10-Q 2024-08-13
Q2 2023 3.38M -4.92B -99.9% Jun 30, 2023 10-Q 2023-07-25
Q1 2023 3.38M -4.58B -99.9% Mar 31, 2023 10-Q 2023-04-18
Q4 2022 50.8B +46.3B +1014% Dec 31, 2022 10-Q 2023-01-19
Q3 2022 3.35M -4.35B -99.9% Sep 30, 2022 10-K 2023-11-20
Q2 2022 4.92B +1.14B +30.2% Jun 30, 2022 10-Q 2022-07-22
Q1 2022 4.58B +1.65B +56.1% Mar 31, 2022 10-Q 2022-04-21
Q4 2021 4.56B +2.3B +102% Dec 31, 2021 10-Q 2022-01-20
Q3 2021 4.35B +2.75B +171% Sep 30, 2021 10-K 2022-11-15
Q2 2021 3.78B +2.18B +136% Jun 30, 2021 10-Q/A 2021-12-22
Q1 2021 2.93B +2.77B +1728% Mar 31, 2021 10-Q 2021-08-18
Q4 2020 2.26B +838M +58.9% Dec 31, 2020 10-Q 2021-08-13
Q3 2020 1.61B +1B +167% Sep 30, 2020 10-K 2021-12-22
Q2 2020 1.61B +1.09B +210% Jun 30, 2020 10-Q 2021-08-05
Q1 2020 161M -217M -57.4% Mar 31, 2020 10-Q 2021-08-05
Q4 2019 1.42B +1.17B +464% Dec 31, 2019 10-Q 2021-08-05
Q3 2019 600M +420M +233% Sep 30, 2019 10-Q 2021-08-05
Q2 2019 518M +360M +227% Jun 30, 2019 10-Q 2019-10-24
Q1 2019 377M +226M +149% Mar 31, 2019 10-Q 2019-08-29
Q4 2018 252M +106M +72.4% Dec 31, 2018 10-Q 2019-02-12
Q3 2018 180M +40.6M +29.1% Sep 30, 2018 10-K 2021-06-21
Q2 2018 159M +20.6M +14.9% Jun 30, 2018 10-Q 2018-08-06
Q1 2018 151M +13.2M +9.57% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 146M +768K +0.53% Dec 31, 2017 10-Q 2018-02-06
Q3 2017 140M -8.45K -0.01% Sep 30, 2017 10-K 2018-12-27
Q2 2017 138M +3.56M +2.65% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 138M +9.86M +7.69% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 145M +30.7M +26.7% Dec 31, 2016 10-Q 2017-01-27
Q3 2016 140M +25M +21.8% Sep 30, 2016 10-Q 2017-01-27
Q2 2016 135M +25.2M +23.1% Jun 30, 2016 10-Q 2016-08-01
Q1 2016 128M +18.9M +17.3% Mar 31, 2016 10-Q/A 2017-04-28
Q4 2015 115M +62.7M +120% Dec 31, 2015 10-Q 2016-01-28
Q3 2015 115M +63.1M +122% Sep 30, 2015 10-Q/A 2017-04-28
Q2 2015 109M +57.4M +111% Jun 30, 2015 10-Q/A 2017-04-28
Q1 2015 109M +57.4M +111% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 52M Dec 31, 2014 10-Q 2015-02-04
Q3 2014 51.6M 0 0% Sep 30, 2014 10-K/A 2017-04-28
Q2 2014 51.9M Jun 30, 2014 10-Q 2014-08-07
Q1 2014 51.9M Mar 31, 2014 10-Q 2014-05-05
Q3 2013 51.6M Sep 30, 2013 10-K 2014-12-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.